MODAFOCUS 400

What is MODAFOCUS 400?

MODAFOCUS 400 is a medicinal drug belonging to the pharmacological group of psychostimulants and nootropic agents, although its clinical profile differs significantly from classic central nervous system stimulants. The main purpose of the drug is to maintain an active wakeful state and correct pathological daytime sleepiness associated with disorders such as narcolepsy. The manufacturer of MODAFOCUS 400 is the pharmaceutical company Kachhela, which specializes in creating high-quality generic drugs with proven bioequivalence to the original molecules. The medication is produced in the form of tablets for oral administration, ensuring convenience of use and precise dosage in an outpatient setting.

The active component of MODAFOCUS 400 is modafinil — a substance that affects the brain's neurotransmitter systems responsible for regulating the "sleep-wake" cycle. Unlike amphetamines, modafinil does not cause pronounced euphoria, has a significantly lower abuse potential, and less frequently leads to the development of dependence. Its action is realized through a complex mechanism that includes inhibition of dopamine reuptake and effects on histamine and orexin receptors, thanks to which the patient experiences mental clarity without excessive excitation. This approach allows the use of the drug in patients who need to maintain high cognitive performance for extended periods.

In medical practice, MODAFOCUS 400 is considered a tool for symptomatic therapy rather than a medicine to treat the underlying cause of the disease. This means that the drug effectively eliminates manifestations of excessive sleepiness, allowing the patient to return to a full social and professional life, but does not affect the etiology of the neurological disorder. It is important to understand that self-administration of modafinil without prior medical examination can mask serious pathologies, particularly sleep apnea or depressive states, which require a different therapeutic strategy. Therefore, the decision to prescribe MODAFOCUS 400 must be made exclusively by a qualified physician after a comprehensive diagnosis.

What is MODAFOCUS 400 prescribed for?

The main indication for the use of MODAFOCUS 400 is narcolepsy — a chronic neurological disorder characterized by uncontrollable daytime sleep attacks, sudden loss of muscle tone, and disrupted nighttime sleep. In such patients, the drug helps stabilize wakefulness levels, reducing the frequency of sudden falling asleep episodes in dangerous situations, such as while driving or operating machinery. Modafinil allows patients with narcolepsy to lead a more predictable lifestyle, plan their workday, and avoid social isolation caused by the fear of an unexpected sleep attack.

The second important field of application for MODAFOCUS 400 is obstructive sleep apnea syndrome, when a patient suffers from chronic daytime sleepiness even when using CPAP therapy. In such cases, the drug is prescribed as an adjunctive agent to improve the quality of wakefulness, especially during periods when device therapy is unavailable or insufficiently effective. Modafinil does not treat the apnea itself, but significantly reduces its consequences associated with cognitive dysfunction and decreased work capacity. A doctor may recommend this approach to patients who continue to complain of fatigue despite complying with all recommendations regarding nighttime breathing.

MODAFOCUS 400 is also used for shift work sleep disorder, when a person is forced to work night shifts or frequently change time zones. The drug helps adapt circadian rhythms to an unconventional schedule, reducing feelings of exhaustion and increasing concentration during hours when the body is physiologically set to sleep. This is especially relevant for medical personnel, long-haul truck drivers, pilots, and emergency response workers. However, it should be remembered that using the drug does not replace full rest, but only temporarily compensates for its deficit.

Composition and active ingredients of MODAFOCUS 400

The main active ingredient of MODAFOCUS 400 is modafinil at a dosage of 400 mg per tablet, which corresponds to the maximum daily dose for most clinical situations. Modafinil is a racemic mixture of two enantiomers that have different pharmacokinetics but synergistically provide a long-lasting wakefulness effect for 12–15 hours after a single dose. The mechanism of action of the substance consists of selective inhibition of the dopamine transporter, which leads to an increase in the concentration of this neurotransmitter in the synaptic cleft, as well as stimulation of histaminergic neurons in the hypothalamus. Unlike traditional psychostimulants, modafinil does not cause significant release of norepinephrine, explaining the lower frequency of cardiovascular complications.

Excipients in MODAFOCUS 400 are selected to ensure optimal bioavailability and stability of the active substance. Among them may be microcrystalline cellulose, starch, magnesium stearate, and povidone, which function as fillers, binding agents, and lubricants. These ingredients have no independent pharmacological activity, but are critically important for ensuring uniform release of modafinil in the gastrointestinal tract. The manufacturer Kachhela uses standardized pharmacopeial substances, guaranteeing reproducibility of the therapeutic effect from batch to batch.

The pharmacokinetic profile of modafinil is characterized by rapid absorption after oral administration, reaching peak plasma concentration in 2–4 hours, and an elimination half-life of about 12–15 hours. The drug is metabolized primarily in the liver with the participation of cytochrome P450, which must be taken into account by patients with diseases of the hepatobiliary system. The excretion of metabolites occurs mainly via the kidneys, so in case of impaired renal function, dosage adjustment or an increase in the interval between doses may be required. Such a profile allows the drug to be used once daily, usually in the morning, which increases patient compliance with treatment.

Dosage of MODAFOCUS 400

The standard therapeutic dose of MODAFOCUS 400 for adult patients is 200 mg once daily; however, in cases of insufficient clinical response, a doctor may increase the dosage to 400 mg, which corresponds to one tablet of the drug. The maximum daily dose should not exceed 400 mg, as a further increase does not lead to a proportional enhancement of the effect, but significantly increases the risk of adverse reactions. For patients with narcolepsy, the drug is usually taken in the morning to ensure alertness throughout an active day and not disrupt nighttime sleep. In case of shift work sleep disorder, modafinil should be taken 1 hour before the start of the work shift.

The duration of the treatment course with MODAFOCUS 400 is determined individually depending on the diagnosis and the patient's response to therapy. In narcolepsy, the drug can be used for a long time, sometimes for years, subject to regular medical monitoring of blood pressure, heart rate, and mental state. For patients with sleep apnea syndrome, modafinil is prescribed in courses, the duration of which depends on the effectiveness of the main CPAP therapy and symptom dynamics. It is important not to interrupt treatment abruptly, as this may cause a withdrawal phenomenon in the form of severe sleepiness and decreased cognitive functions.

Dosage adjustment of MODAFOCUS 400 is necessary for elderly patients in whom drug metabolism may be slowed down, increasing the risk of accumulation and toxic effects. Such patients are recommended to start therapy with a minimum effective dose of 100 mg, if an appropriate dosage form is available, or use half of a 400 mg tablet as prescribed by a physician. In patients with severe hepatic impairment, the daily dose should be reduced by half, as modafinil is metabolized primarily in the liver. Any dosage change should occur only after consultation with a doctor who will assess the benefit-to-risk ratio.

How to take MODAFOCUS 400 correctly?

MODAFOCUS 400 should be taken orally with plenty of water, regardless of food intake, although taking the drug with food may slightly delay its absorption. To achieve the maximum effect, it is recommended to take the tablet in the morning, immediately after waking up, or one hour before the start of a work shift during shift work. MODAFOCUS 400 should not be taken in the afternoon or evening, as this can cause insomnia and disrupt the natural circadian rhythm. The tablet should be swallowed whole, without chewing or crushing, to ensure uniform release of the active substance.

If a patient misses a dose of MODAFOCUS 400, it is necessary to take the drug as soon as possible, provided that there are at least 8 hours remaining until the next scheduled dose. If the missed dose is noticed late, it is better to skip it and continue treatment according to the regular schedule to avoid double dosing. Doubling the dose to compensate for a missed one is strictly prohibited, as this increases the risk of developing serious side effects, such as tachycardia, arterial hypertension, and psychomotor agitation. Consistency of administration is a key factor in maintaining a stable concentration of the drug in the blood.

During treatment with MODAFOCUS 400, it is necessary to adhere to a healthy sleep regimen, even if the drug temporarily reduces the feeling of fatigue. Patients should avoid consuming large amounts of caffeinated beverages, as this can enhance the stimulating effect and cause tremors, anxiety, or heart rhythm disturbances. It is also important to regularly monitor blood pressure and pulse rate, especially during the first weeks of therapy, as modafinil can increase sympathetic activity. If any unusual symptoms appear, such as chest pain, severe palpitations, or mental disorders, medical help should be sought immediately.

Side effects of MODAFOCUS 400

The most common side effects of MODAFOCUS 400 are headache, insomnia, decreased appetite, and dry mouth, which usually occur at the beginning of treatment and are transient in nature. Headache may be associated with the vasoconstrictive effect of the drug and changes in brain vascular tone, so adequate fluid intake and avoiding excessive visual strain are recommended for relief. Insomnia is observed more often in patients who take the drug later than the recommended time or exceed the prescribed dose. Decreased appetite can lead to slight weight loss, which requires monitoring, especially in underweight patients.

Uncommon adverse reactions of MODAFOCUS 400 include tachycardia, increased blood pressure, anxiety, irritability, and gastrointestinal disorders, such as nausea or diarrhea. These symptoms may require a temporary dose reduction or symptomatic therapy, but are usually not a reason for complete discontinuation of the drug. In patients with latent psychiatric disorders, modafinil can trigger an exacerbation of anxious or depressive states; therefore, a thorough history taking is necessary before starting treatment. Special attention should be paid to patients with cardiovascular diseases, as the stimulating effect of the drug can increase the workload on the myocardium.

Rare but serious side effects of MODAFOCUS 400 include allergic reactions, including angioedema and anaphylaxis, as well as Stevens-Johnson syndrome — a severe lesion of the skin and mucous membranes requiring immediate hospitalization. Patients should consult a doctor immediately if a rash, blisters, facial swelling, or difficulty breathing appear, as these symptoms may indicate a life-threatening reaction. Cases of psychotic episodes, hallucinations, and manic states have also been reported, especially in patients with a history of bipolar disorder. Any unusual change in mental state while taking the drug is a reason for an urgent consultation with a physician.

Contraindications of MODAFOCUS 400

Absolute contraindications to the use of MODAFOCUS 400 are hypersensitivity to modafinil or any auxiliary component of the drug, as well as a history of severe allergic reactions to other psychostimulants. The drug is not prescribed to patients with uncontrolled arterial hypertension or severe heart rhythm disorders, as the stimulating effect on the sympathetic nervous system can trigger a hypertensive crisis or arrhythmia. MODAFOCUS 400 is also prohibited in psychotic disorders, including schizophrenia and bipolar affective disorder, due to the risk of exacerbating psychopathological symptoms. In patients with severe hepatic insufficiency, the drug is contraindicated due to impaired metabolism and a high risk of toxic accumulation.

Relative contraindications requiring special caution include ischemic heart disease, left ventricular hypertrophy, epilepsy, and renal insufficiency. In such cases, MODAFOCUS 400 can be used only under close monitoring of the clinical condition and in the absence of safer alternatives. The drug is not recommended for use during pregnancy, as data regarding the safety of modafinil for the fetus are limited, and experimental studies have revealed a potential teratogenic effect. Women of childbearing potential should use reliable methods of contraception during treatment and for two months after its completion.

MODAFOCUS 400 is not intended for use in children and adolescents under 18 years of age, as the safety and efficacy of the drug in this age group have not been established. In elderly patients, the drug may be prescribed with caution, starting with minimal doses, due to an increased risk of cardiovascular complications and sleep disturbances. Individuals with a history of substance abuse should use MODAFOCUS 400 under strict medical supervision, as modafinil has a certain potential for abuse, although significantly lower than that of classic stimulants. Before starting therapy, the doctor must evaluate all risks and conduct a full examination of the patient.

Interaction of MODAFOCUS 400 with other drugs and alcohol

MODAFOCUS 400 can interact with medicines metabolized through the cytochrome P450 system, particularly with oral contraceptives, the effectiveness of which is reduced due to the acceleration of their metabolism. Female patients taking hormonal contraceptives should use additional barrier methods of protection during treatment with modafinil and for one month after its discontinuation. Concomitant use with anticoagulants (warfarin) may require adjustment of the dose of the latter due to changes in their metabolism; therefore, regular monitoring of the international normalized ratio is required. Modafinil can also enhance the effect of antidepressants and antiepileptic drugs, which calls for caution during combination therapy.

Alcohol consumption during treatment with MODAFOCUS 400 is not recommended, as ethanol can enhance the side effects of the drug on the central nervous system, such as dizziness, impaired coordination, and drowsiness. In addition, alcohol is able to mask or distort the therapeutic effect of modafinil, making it difficult to assess dosage adequacy. The drug can affect the ability to drive vehicles and operate machinery, especially at the beginning of treatment or when changing the dose; therefore, patients should refrain from such activities until individual response is clarified. It is important to remember that modafinil does not eliminate the physiological need for sleep, but only temporarily suppresses it, so prolonged neglect of rest can lead to dangerous consequences.

Where to buy MODAFOCUS 400 in Ukraine

MODAFOCUS 400 is available in pharmacy chains in Ukraine, as well as in specialized online pharmacies that deliver medicines throughout the country. The drug is dispensed by prescription, as it belongs to the category of psychostimulants requiring strict control of circulation. Patients are recommended to purchase MODAFOCUS 400 only in certified pharmacy establishments to avoid the risk of buying counterfeit products that may not meet quality standards. Before purchasing, it is worth checking the availability of the drug in several pharmacies, as demand for modafinil can cause temporary shortages.

MODAFOCUS 400 must be stored in its original packaging at a temperature not exceeding 25 °C in a dry place, protected from light and inaccessible to children. The shelf life of the drug is usually 2–3 years from the date of manufacture, after which the use of the medicine is strictly prohibited. When ordering online, you should pay attention to the seller's reputation and the availability of a license for retail trade in pharmaceuticals. Before starting to take MODAFOCUS 400, be sure to consult a doctor, as self-treatment can be dangerous to health, and the individual body response to the drug may differ from expected.